Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, ClearBridge Investments International Growth ADR Strategy. This analysis is provided for institutional research purposes only and is not investment advice.
"The Strategy navigated historic value-over-growth headwinds in 2025 by selectively adding to structural value plays like European banks and optimizing healthcare holdings, while remaining constructive on international valuations and AI infrastructure."
In the fourth quarter of 2025, the ClearBridge International Growth ADR Strategy underperformed its primary MSCI EAFE benchmark due to extreme style dispersion favoring value stocks over growth. While the Strategy lagged core benchmarks, it outperformed its growth benchmark over the full year. Key portfolio actions during the quarter included a focus on healthcare rotation (adding Roche, Galderma, and EssilorLuxottica, while exiting Novo Nordisk) and increasing exposure to structural growth, particularly European and U.K. banks like NatWest. The managers remain constructive on the outlook for overseas growth equities, emphasizing that international valuations are attractive and poised to benefit from structural trends such as AI workloads and rising non-U.S. defense budgets.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: The Strategy navigated historic value-over-growth headwinds in 2025 by selectively adding to structural value plays like European banks and optimizing healthcare holdings, while re...
Growth Outlook
Market outlook remains above average conviction: The Strategy navigated historic value-over-growth headwinds in 2025 by selectively adding to structural value plays like European banks and optimizing healthcare holdings, while re...
Risk Appetite
Risk appetite posture is above average conviction: The Strategy navigated historic value-over-growth headwinds in 2025 by selectively adding to structural value plays like European banks and optimizing healthcare holdings, while re...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The Strategy navigated historic value-over-growth headwinds in 2025 by selectively adding to structural value plays like European banks and optimizing healthcare holdings, while re...
Forward Guidance
Forward guidance signal: The Strategy navigated historic value-over-growth headwinds in 2025 by selectively adding to structural value plays like European banks and optimizing healthcare holdings, while re...
Language Signal
Tone analysis indicates above average conviction language: The Strategy navigated historic value-over-growth headwinds in 2025 by selectively adding to structural value plays like European banks and optimizing healthcare holdings, while re...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. The Strategy navigated historic value-over-growth headwinds in 2025 by selectively adding to structural value plays like European banks and optimizing healthcare holdings, while re...
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. The Strategy navigated historic value-over-growth headwinds in 2025 by selectively adding to structural value plays like European banks and optimizing healthcare holdings, while re...
Time Horizon
Investment time horizon reflects a high conviction orientation. The Strategy navigated historic value-over-growth headwinds in 2025 by selectively adding to structural value plays like European banks and optimizing healthcare holdings, while re...
